Zusammenfassung
Das Gebiet der Tumorimmunologie ist in den letzten Jahren rasch gewachsen, da immunologische Methoden auf vielen Gebieten der Krebsforschung angewandt werden. Insbesondere sind sie dazu benutzt worden, Veränderungen in den Tumorzellen selbst nachzuweisen, wie z.B. 1. die Entwicklung neuer antigener Determinanten in Krebszellen und in mit onkogenen Viren infizierten Zellen, 2. den Verlust oder die Verminderung normaler Zellkomponenten und 3. die Synthese löslicher Produkte durch Krebszellen, wie z.B. Myelomproteine. Immunologische Methoden sind aber auch bei der Untersuchung des Krebsträgers angewandt worden, nämlich beim Nachweis spezifischer Immunreaktionen gegenüber wachsenden Tumoren und bei der Untersuchung der Wirkung von Tumoren auf die immunologische Potenz des Tumorträgers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aaronson, S.A., Hartley, J.W., Todaro, G.J.: Mouse leukemia virus: “Spontaneous” release by mouse embryo cells after longterm in vitro cultivation. Proc. nat. Acad. Sci. (Wash.) 64, 87–94 (1969).
Abelev, G.I., Assecritova, I.V., Kraevsky, N.A., Perova, S.D., Perevodchikova, N.I.: Embryonal serum α-globulin in cancer patients: Diagnostic value. Int. J. Cancer 2, 551–561 (1967).
Ahlström, C.G., Forsby, N.: Sarcomas in hamsters after injection with Rous chicken tumor material. J. exp. Med. 115, 839–852 (1962).
Alpert, M.E., Uriel, J., De Nechaud, B.: Alpha fetoglobulin in the diagnosis of human hepatoma. New Engl. J. Med. 278, 984–986 (1968).
Anderson, V., Bjerrum, O., Bendixen, G., Schiodt, T., Dissing, I.: Effect of autologous mammary tumor extracts on human leukocyte migrations in vitro. Int. J, Cancer 5, 357–363 (1970).
Aoki, T., Boyse, E.A., Old, L.J.: Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice. J. nat. Cancer Inst. 41, 89–96 (1968).
Aoki, T., Boyse, E.A., Old, L.J., de Harven, E., Hämmerling, U., Wood, H.A.: G (Gross) and H-2 cell-surface antigens: Location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc. nat. Acad. Sci. (Wash.) 65, 569–576 (1970).
Aoki, T., Takahashi, T.: Viral and cellular surface antigens of murine leukemias and myelomas. J. exp. Med. 135, 443–457 (1972).
Armstrong, D., Okuyan, M., Huebner, R.J.: Complement-fixing antigens in tissue cultures of avian leucosis viruses. Science 144, 1584–1587 (1964).
Attia, M.A.M., Weiss, D.W.: Immunology of spontaneous mammary carcinomas in mice. V. Acquired resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res. 26, 1787–1800 (1966).
Axelrad, A. A.: Changes in resistance to the proliferation of isotransplanted Gross virus induced lymphoma cells, as measured with a spleen colony assay. Nature (Lond.) 199, 80–83 (1963).
Axelrad, A.: Antigenic behaviour of lymphoma cell populations in mice as revealed by the spleen colony method. Progr. exp. Tumor Res. 6, 31–83 (1965).
Baldwin, R.S., Barker, C.R.: Tumor immunity. Induction of immunity to aminoazo dye-induced rat liver tumours. British Empire Cancer Campaign for Research Annual Report, p. 386–397 (1964).
Baldwin, R.W., Embleton, M.J.: Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumor-specific antigens associated with aminoazo-dye-induced rat hepatomas. Int. J. Cancer 7, 17–25 (1971).
Barski, G.: Cell association and somatic cell hybridization. Int. Rev. exp. Path. 9, 151–155 (1970).
Barski, G., Youm, J.K.: Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal. J. nat. Cancer Inst. 43, 111–122 (1969).
Batchelor, J.R., Boyse, E.A., Gorer, P.A.: Synergic action between isoantibody and immune cells in graft rejection. Transplant. Bull. 26, 449–453 (1960).
Batchelor, J.R., Tuffrey, M.A.: Tumour specific immunity against murine epitheliomas induced with 9,10-dimethyl-1,2-benzanthracene. Nature (Lond.) 204, 349–351 (1964).
Beale, R.: The antigen system of Paramecium aurelia. Int. Rev. Cytol. 6, 1–8 (1957).
Beisson, J., Sonneborn, T. M.: Cytoplasmic inheritance of the organization of the cell cortex in Paramecium aurelia. Proc. nat. Acad. Sci. (Wash.) 53, 275–282 (1965).
Berman, L.D., Rowe, W.P.: A study of the antigens involved in adenovirus 12 tumorigenesis by immunodiffusion techniques. J. exp. Med. 121, 955–968 (1965).
Berman, L. D., Sarma, P.A.: Demonstration of an avian leucosis group antigen by immunodiffusion. Nature (Lond.) 207, 263–265 (1965).
Bianco, A.R., Glynn, J.P., Goldin, A.: Immunity against isotransplants of Rauscher virusin-duced leukemia. Proc. Amer. Ass. Cancer Res. 5, 5 (1965).
Biggs, P. M., Churchill, A. E., Rootes, D.G., Chubb, R.C.: The etiology of Marek’s disease—an oncogenic Herpes-type virus. In: Perspectives in virology VI., p. 211–237. New York: Academic Press 1968.
Black, P.H., Rowe, W.P., Turner, H.C., Huebner, R.J.: A specific complement-fixing antigen present in SV40 tumor and transformed cells. Proc. nat. Acad. Sci. (Wash.) 50, 1148–1156 (1963).
Blair, P. B.: Immunology of the mouse Mammary Tumor Virus (MTV): A qualitative in vitro assay for MTV. Nature (Lond.) 208, 165–167 (1965).
Bloom, B.R., Bennet, B., Oettgen, H.F., McLean, E.P., Old, L.J.: Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration. Proc. nat. Acad. Sci. (Wash.) 64, 1176–1180 (1969).
Bloom, B.R., Jiminez, L., Marcas, P.I.: A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J. exp. Med. 132, 16–30 (1970).
Bower, B.F., Gordan, G.S.: Hormonal effects of nonendocrine tumors. Ann. Rev. Med. 16, 83–118 (1965).
Boyse, E.A.: Immune responses to experimental tumours. Guy’s Hosp. Rep. 112, 433–448 (1963).
Boyse, E.A., Old, L.J.: Some aspects of normal and abnormal cell surface genetics. Ann. Rev. Genet. 3, 269–290 (1969).
Boyse, E. A., Old, L.J.: The invitation to surveillance. In: Smith, R. T., Landy, M., eds.: Immune surveillance, p. 5–30. New York: Academic Press.
Boyse, E. A., Old, L. J., Luell, S.: Antigenic Properties of Experimental Leukemias. II. Immunological Studies in: Vivo with C57BL/6 radiation induced leukemias. J. nat. Cancer Inst. 31, 987–995 (1963).
Boyse, E. A., Old, L. J., Luell, S.: Genetic determination of the TL (thymus-leukaemia) antigen in the mouse. Nature (Lond.) 201, 779 (1964).
Boyse, E. A., Old, L.J., Oettgen, H. F.: Tumor immunology. In: Miescher, P.A., Muller-Eberhard, H.J., eds.: Textbook of immunopathology, p. 768–788. New York: Grune and Stratton 1969.
Boyse, E. A., Old, L. J., Stockert, E.: The TL (thymus leukemia) antigen: a review. In: Grabar, P., Miescher, P.A., eds.: Immunopathology. 4th Intern. Symp. 1965, p. 23–40. Basel: Schwabe & Co. 1966.
Boyse, E.A., Old, L.J., Stockert, E.: In: Emmelot, P., Bentvelzen, P., eds.: RNA viruses and host genome in oncogenesis, p. 171–185. Amsterdam: North-Holland Publ. 1972.
Boyse, E.A., Old, L.J., Stockert, E., Shigeno, N.: Genetic origin of tumor antigens. Cancer Res. 28, 1280–1287 (1968).
Boyse, E. A., Stockert, E., Old, L. J.: Modification of the antigenic structure of the cell membrane by TL antibody. Proc. natl. Acad. Sci. (Wash.) 58, 954–957 (1967).
Bubenik, J., Koldovsky, P.: Factors influencing the induction of enhancement and resistance to methyl-cholanthrene-induced tumors in a syngeneic system. Folia biol. 11, 258 (1965).
Burnet, F.M.: The concept of immunological surveillance. In: Schwartz, R.S., ed.: Progress in experimental tumor research. Immunological aspects of neoplasia. Vol. 13, p. 1–27. Basel: S. Karger 1970.
Chembroniewicz, J., Kolar, O.: Tissue culture study of glioblastoma cells with addition of autologous lymphocytes. Acta cytol. (Philad.) 13, 42–47 (1969).
Chu, E. H. Y., Stjernswar, J., Clifford, P., Klein, G.: Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro. J. nat. Cancer Inst. 39, 595–617 (1967).
Churchill, W.H., Rapp, H., Kronman, B.S., Borsos, T.: Detection of antigens of a new diethylnitrosamine-induced transplantable hepatoma by delayed hypersensitivity. J. nat. Cancer Inst. 41, 13–29 (1968).
Datta, S.K., van de Putte, M.: Studies on cellular and humoral immunity to tumor specific antigens in polyoma virus induced tumors of rats. Cancer Res. 31, 882–889 (1971).
Davies, D.A.L., Boyse, E.A., Old, L.J., Stockert, E.: Mouse isoantigens: Separation of soluble TL (thymus leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. J. expt. Med. 125, 549–558 (1967).
Day, E.D.: The immunochemistry of cancer, p. 125–135. Springfield, Illinois: Charles C. Thomas 1965.
Defendi, V.: Effect of SV40 virus immunization on growth of transplantable SV40 and polyoma virus tumors in hamsters. Proc. Soc. exp. Biol. (N. Y.) 113, 12–16 (1963).
Defendi, V.: Transformation in vitro of mammalian cells by polyoma and Simian 40 viruses. In: Homburger, F., ed.: Progr. expt. Tumor Res., vol. 8, p. 125 188. New York: S. Karger 1966.
Defendi, V., Ephrussi, B., Koprowski, H.: Expression of polyoma-induced cellular antigen (s) in hybrid cells. Nature (Lond.) 203, 495–496 (1964.
Defendi, V., Roosa, R.A.: The role of the thymus in carcinogenesis. In: The thymus. Wistar Inst. Monograph No. 2, p. 121–135. Philadelphia: Wistar Inst. Press 1964.
Deichman, G.I., Kluchareva, T.F.: Immunological determinants of oncogenesis in hamsters infected with SV40 virus. Virology 24, 131–137 (1964).
Dulbecco, R.: Cell Transformation by the small DNA-Containing Viruses. Harvey Lect. 63, 33–46 (1969).
Eddy, B. E., Grubbs, G. E., Young, R. D.: Tumor immunity in hamsters infected with adenovirus type 12 and simian virus 40. Proc. Soc. exp. Biol. (N. Y.) 117, 575–579 (1964).
Edynak, E.M., Old, L.J., Vrana, M., Lardis, M.: A fetal antigen in human tumors detected by antibody in the serum of cancer patients. Proc. Amer. Ass. Cancer Res. 11, 22 (1970).
Eilber, F.R., Morton, D.L.: Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (Philad.) 26, 588–596 (1970).
Epstein, M.A.: Aspects of the EB virus. Advanc. Cancer Res. 13, 384–412 (1970).
Evans, C. A., Gorman, L. R., Ito, Y., Weiser, R. S.: Antitumor immunity in the Shope papillomacarcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccine. J. nat. Cancer Inst. 29, 277–285 (1962).
Evans, C.A., Weiser, R.S., Ito, Y.: Antiviral and antitumor immunologic mechanisms operative in the Shope papilloma-carcinoma system. Symp. quant. Biol. 27, 453–462 (1962).
Fass, L., Herberman, R., Ziegler, J.: Cutaneous hypersensitivity to extracts of Burkitt lymphoma cells. New Engl. J. Med. 282, 776–780 (1970).
Fass, L., Herberman, R.B., Ziegler, J.L., Kiryabwire, J.W.H.: Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet 1970 I, 116–118.
Fink, M.A.: Some immunological cross-reactions among murine leukemia viruses. Proc. Amer. Ass. Cancer Res. 5, 18 (1964).
Fink, M. A.: Immunological studies on leukemia viruses. In: Viral etiology of leukemia. Combined Clinical Staff Conference at the National Institutes of Health. Ann. intern. Med. 62, 389–393 (1965).
Fink, M.A., Malmgren, R.A.: Fluorescent antibody studies of the viral antigen in a murine leukemia (Rauscher). J. nat. Cancer Inst. 31, 1111–1121 (1963).
Fink, M.A., Rauscher, F.J.: Immune reactions to a murine leukemia virus. I. Induction of immunity to infection with virus in the natural host. J. nat. Cancer Inst. 32, 1075–1082 (1964).
Fink, M.A., Sibal, L.R., Plata, E.J.: Serologic detection of feline leukemia virus antigens or antibodies. J. Amer. vet. med. Ass. 158, 1070–1075 (1971).
Foley, E.J.: Antigenic Properties of Methylcholanthreneinduced tumors in mice of the strain of origin. Cancer Res. 13, 835–837 (1953).
Fridman, W.H., Kourilsky, F.M.: Stimulation of lymphocytes by autologous leukemia cells in acute leukemia. Nature (Lond.) 224, 277–278 (1969).
Friend, C.: Immunological relationships of a filterable agent causing a leukemia in adult mice. I. The neutralization of infectivity by specific antiserum. J. exp. Med. 109, 217–228 (1959).
Geering, G., Aoki, T., Old, L.J.: Shared viral antigen of mammalian leukaemia viruses. Nature (Lond.) 226, 265–266 (1970).
Geering, G., Old, L.J., Boyse, E.A.: Antigens of leukemias induced by a naturally occurring murine leukemia virus. Their relation to the antigens of Gross virus and other murine viruses. J. exp. Med. 124, 753–772 (1966).
Gerald, P.S.: The abnormal haemoglobins. In: Penrose, L.S., ed.: Recent advances in human genetics, p. 76–100. Boston: Little, Brown & Co. 1961.
Gerber, P., Moore, J.H.: Studies in leukocytes growing in continuous cultures derived from normal human donors. J. nat. Cancer Inst. 40, 855–866 (1968).
Gilden, R.V., Carp, R.I., Laguchi, F., Defendi, V.: The nature and localization of the SV40-induced complement-fixing antigen. Proc. nat. Acad. Sci. (Wash.) 53, 684–692 (1965).
Gilden, R.V., Oroszlan, S.: Group-specific antigens of RNA tumor viruses as markers for subinfectious expression of the RNA virus genome. Proc. nat. Acad. Sci. (Wash.) 69, 1021–1032 (1972).
Giraldo, G., Beth, E., Hirshaut, Y., Aoki, T., Old, L.J., Boyse, E. A., Chopra, H.C.: Human sarcomas in culture. Foci of altered cells and a common antigen; induction of foci and antigen in human fibroblast cultures by filtrates. J. exp. Med. 133, 454–478 (1971).
Glynn, J.P., Bianco, A.R., Goldin, A.: Studies on induced resistance against isotransplants of virusinduced leukemia. Cancer Res. 24, 502–508 (1964).
Gold, P., Freedman, S.O.: Demonstration of tumorspecific antigens in human colonic carcino-mata by immunologic tolerance and absorption techniques. J. exp. Med. 121, 439–462 (1965).
Gold, P., Freedman, S.O.: Specific carcinoembryonic antigens of the human digestive system. J. exp. Med. 121, 467–481 (1965).
Gold, P., Gold, M., Freedman, S.O.: Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res. 28, 1331–1334 (1968).
Goldner, H., Girardi, A.J., Larson, V.M., Hilleman, M.R.: Interruption of SV40 virus tumorigenesis using irradiated homologous tumor antigen. Proc. Soc. exp. Biol. (N.Y.) 117, 851–861 (1964).
Good, R.A., Finstadt, J.: Essential relationship between the lymphoid system, immunity, and malignancy. Nat. Cancer Inst. Monogr. No. 31, 41–58 (1969).
Gorer, P.A.: Some recent work on tumor immunity. Advance Cancer Res. 4, 149–186 (1956).
Gross, L.: Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res. 3, 326–331 (1943).
Gross, L.: The specificity of acquired tumor immunity. J. Immunol. 50, 91–99 (1945).
Gross, L.: Pathogenic properties, and “vertical” transmission of the mouse leukemia agent. Proc. Soc. exp. Biol. (N.Y.) 78, 342–356 (1951).
Gross, L.: Oncogenic viruses, p. 1–393. Oxford: Pergamon Press 1961.
Habel, K.: Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc. Soc. exp. Biol. (N.Y.) 106, 722 725 (1961).
Habel, K.: Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc. Soc. exp. Biol. (N.Y.) 106, 722–725 (1961).
Habel, K.: The relationship between polyoma virus multiplication, immunological competence and resistance to tumor challenge in the mouse. Ann. N.Y. Acad. Sci. 101, 173–180 (1962).
Habel, K.: Specific complement-fixing antigens in polyoma tumors and transformed cells. Virology 25, 55–61 (1965).
Habel, K., Eddy, B. E.: Specificity of resistance to tumor challenge of polyoma and SV40 virus immune Hamsters. Proc. Soc. exp. Biol. (N.Y.) 113, 1–4 (1963).
Habel, K., Jensen, F., Pagano, J. S., Koprowski, H.: Specific complement-fixing tumor antigen in SV40 transformed human cells. Proc. Soc. exp. Biol. (N.Y.) 118, 4–9 (1965).
Halliday, W. J.: Blocking effect of serum from tumorbearing animals on macrophage migration inhibition with tumor antigens. J. Immunol. 106. 855–857 (1971).
Hanafusa, H., Hanafusa, T., Rubin, H.: The defectiveness of Rous sarcoma virus. Proc. nat. Acad. Sci. (Wash.) 49, 572 580 (1963).
Hanafusa, H., Hanafusa, T., Rubin, H.: Analysis of the defectiveness of Rous sarcoma virus. I. Characterization of the helper virus. Virology 22, 591–601 (1964).
Hanafusa, H., Hanafusa, T., Rubin, H.: Analysis of the defectiveness of Rous sarcoma virus. II. Specification of RSV antigenicity by helper virus. Proc. nat. Acad. Sci. (Wash.) 51, 41–48 (1964).
Hardy, W.D., Jr., Geering, G., Old, L.J., de Harven, E., Feline leukemia virus: Occurrence of viral antigen in the tissues of cats with lymphosarcoma and other diseases. Science 166, 1019–1021 (1969).
Harris, H.: Cell fusion, p. 1–108. Cambridge, Massachusetts: Harvard Univ. Press.
Hauschka, T.S.: Immunologic aspects of cancer: A review. Cancer Res. 12, 615–633 (1952).
Hauschka, T.S., Kvedar, B.J., Grinnell, S.T., Amos, D.B.: Immunoselection of polypoids from predominantly diploid cell populations. Ann. N.Y. Acad. Sci. 63, 683–710 (1956).
Hellström, I., Evans, C.A., Hellström, K.E.: Cellular immunity and its serum mediated inhibition in Shope virus induced rabbit papillomas. Int. J. Cancer 4, 601–607 (1969).
Hellström, I., Hellström, K. E.: Studies on cellular immunity and its serum mediated inhibition in Moloney virus induced mouse sarcomas. Int. J. Cancer 4, 587–600 (1969).
Hellström, I., Hellström, K.E.: Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to Moloney sarcomas. Int. J. Cancer 5, 195–201 (1970).
Hellström, I., Hellström, K.E., Pierce, G.E.: In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int. J. Cancer 3, 467–482 (1968).
Hellström, I., Hellström, K.E., Pierce, G.E., Fefer, A.: Studies on immunity to autochthonous mouse tumors. Transplant. Proc. 1, 90 94 (1969).
Hellström, I., Hellström, K.E., Bill, A.H., Pierce, G.E., Yang, J.P.S.: Studies on cellular immunity to human neuroblastoma cells. Int. J. Cancer 6, 172–188 (1970).
Hellström, I., Hellström, K.E., Sjögren, H.O.: Serum mediated inhibition of cellular immunity to methylcholanthrene induced murine sarcomas. Cellular Immunol. 1, 18–30 (1970).
Hellström, I., Hellström, K.E., Sjögren, H.D., Warner, G.A.: Demonstration of cellme-diated immunity to human neoplasms of various histological types. Int. J. Cancer 7, 1–16 (1971).
Hellström, K.E., Hellström, I.: Cellular immunity against tumor antigens. Advanc. Cancer Res. 12, 167–223 (1969).
Hellström, K.E., Hellström, I.: Immunological enhancement as studied by cell culture techniques. Ann. Rev. Microbiol. 24, 373–389 (1970).
Henle, G., Henle, W., Diehl, V.: Relation of Burkitt’s tumor associated herpes-type virus to infectious mononucleosis. Proc. nat. Acad. Sci. (Wash.) 59, 94–101 (1968).
Henle, W., Henle, G.: Present status of the Herpesgroup virus associated with cultures of the hematopoietic system. In: Perspectives in virology VI, p. 105–124. New York: Academic Press 1968.
Heppner, G.H.: Studies on serum-mediated inhibition of cellular immunity to spontaneous mouse mammary tumors. Int. J. Cancer 4, 608–615 (1969).
Heppner, G.H., Kopp, J.S.: A dilute agar colony inhibition CI test for studying cell-mediated immune responses against tumor cells. Int. J. Cancer 7, 26–33 (1971).
Heppner, G.H., Pierce, G.: In vitro demonstration of tumor-specific antigens in spontaneous mammary tumors of mice. Int. J. Cancer 4, 212–218 (1969).
Hoggan, M.D., Rowe, W.P., Black, P.H., Huebner, R.J.: Production of “tumor specific” antigens by oncogenic viruses during acute cytolytic infections. Proc. nat. Acad. Sci. (Wash.) 53, 12–19 (1965).
Hollinshead, A., Glew, D., Bunnag, B., Gold, P., Herberman, R.: Skin-reactive soluble antigen from interstinal cancer-cell membranes and relationship to carcinoembryonic antigens. Lancet 1970 I, 1191–1194.
Huebner, R.J.: The murine leukemia-sarcoma virus complex. Proc. nat. Acad. Sci. (Wash.) 58, 835–845 (1967).
Huebner, R.J.: Non-virion neoantigens in cells infected with and transformed by viruses. In: Harris, R.J.C., ed.: Specific tumour antigens, UICC Monograph Series, vol. 2, p. 265–272. New York: Medical Examination Publishing Co., Inc. 1967.
Huebner, R.J.: In: Dutcher, R.M., ed.: Comparative leukemia research 1969, p. 22–44 (Bibl. haemat. 36). Basel: Karger 1970.
Huebner, R.J., Armstrong, D., Okuyan, M., Sarma, P.S., Turner, H.C.: Specific complementfixing viral antigens in hamster und guinea pig tumors induced by the Schmidt-Ruppin strain of avian sarcoma. Proc. nat. Acad. Sci. (Wash.) 51, 742–750 (1964).
Huebner, R. J., Pereira, H.G., Allison, A.C., Hollinshead, A.C., Turner, H.C.: Production of type-specific C antigen in virus-free Hamster Tumor Cells Induced by Adenovirus Type 12. Proc. nat. Acad. Sci. (Wash.) 51, 432–439 (1964).
Huebner, R. J., Rowe, W. P., Turner, H. C., Lane, W. T.: Specific adenovirus complement-fixing antigens in virusfree hamster and rat tumors. Proc. nat. Acad. Sci. (Wash.) 50, 379–389 (1963).
Huebner, R.J., Todaro, G.J.: Oncogenes of RNA tumor viruses as determinants of cancer. Proc. nat. Acad. Sci. (Wash.) 64, 1087–1094 (1969).
Huggins, C., Moon, R.C., Mori, S.: Extinction of experimental mammary cancer. I Estradiol-17ß and progesterone. Proc. nat. Acad. Sci. (Wash.) 48, 379–386 (1962).
Hughes, I.F., Lytton, B.: Antigenic properties of human tumors: Delayed cutaneous hypersensitivity reactions. Brit. med. J. 1964 I, 209–212.
Jehn, U.W., Nathanson, L., Schwartz, R.S., Skinner, M.: In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma. New Engl. J. Med. 283, 329–333 (1970).
Jonsson, N.: Cellmediated and humoral immune responses to tumor-associated and viral antigens in relation to the pathogenic effect of Rous sarcoma virus in rats. Int. J. Cancer 7, 547–554 (1971).
Jonsson, N., Sjögren, H.O.: Further studies on specific transplantation antigens in Rous sarcoma of mice. J. exp. Med. 122, 403–421 (1965).
Kaliss, N.: Immunological enhancement of tumor homografts in mice. A review. Cancer Res. 18, 992–1003 (1958).
Khera, K.S., Ashkenazi A., Rapp, F., Melnick, J.L.: Immunity in hamsters to cells transformed in vitro and in vivo by SV40. J. Immunol. 91, 604–619 (1963).
Kidd, J.G., Beard, J. W., Rous, P.: Serological reactions with a virus causing rabbit papillomas which become cancerous. I. Tests of the blood of animals carrying the papilloma. J. exp. Med. 64, 63–78 (1936).
Kitahara, T., Butel, J.S., Rapp, F., Melnick, J.L.: Correlation between complement-fixing cell antibody and immunofluorescence nuclear antibody in hamsters bearing SV40-induced tumors. Nature (Lond.) 205, 717 (1965).
Klein, E.: Tumors of the skin. X. Immunotherapy of cutaneous and mucosal neoplasms. N. Y. State J. Med. 68, 900–911 (1968).
Klein, E.: Studies on the mechanism of isoantigenic variant formation in heterozygous mouse tumors. I. Behavior of H-2 antigens D and K.: Quantitative absorption tests on mouse sarcomas. J. nat. Cancer Inst. 27, 1069–1093 (1961).
Klein, E., Klein, G.: Mouse antibody production test for the assay of the Moloney virus. Nature (Lond.) 204, 339–342 (1964).
Klein, E., Klein, G.: Antigenic properties of lymphomas induced by the Moloney agent. J. nat. Cancer Inst. 32, 547–568 (1964).
Klein, E., Sjögren, H.O.: Humoral and cellular factors in homograft and isograft immunity against sarcoma cells. Cancer Res. 20, 452–461 (1960).
Klein, G.: Herpesviruses and oncogenesis. Proc. nat. Acad. Sci. (Wash.) 69, 1056–1064 (1972).
Klein, G.: Some immunological studies. In: Burkitt, D.P., Wright, D.H., eds.: Burkitt’s lymphoma, p. 172–185. Edinburgh: E. and S. Livingstone 1970.
Klein, G., Geering, G., Old, L.J., Henle, W., Clifford, P.: Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls. Int. J. Cancer 5, 185–194 (1970).
Klein, G., Klein, E.: Detection of an allelic difference at a single gene locus in a small fraction of a large tumour-cell population. Nature (Lond.) 178, 1389–1391 (1956).
Klein, G., Klein, E.: Antigenic properties of other experimental tumors. Symp. quant. Biol. 27, 463–470 (1962).
Klein, G., Klein, E.: Antigenic behavior of Moloney lymphomas: Independence of virus release and immunosensitivity. Science 145, 1316–1317 (1964).
Klein, G., Sjögren, H.O., Klein, E.: Demonstration of host resistance against isotransplantation of lymphomas induced by the Gross agent. Cancer Res. 22, 955–961 (1962).
Klein, G., Sjögren, H. O., Klein, E.: Demonstration of host resistance against sarcomas induced by implantation of cellophane films in isologous (syngeneic) recipients. Cancer Res. 23, 84–92 (1963).
Klein, G., Sjögren, H.O., Klein, E., Hellström, K.E.: Demonstration of resistance against methylcholanthreneinduced sarcomas in the primary autochthonous host. Cancer Res. 20, 1561–1572 (1960).
Koch, M.A., Sabin, A.B.: Specificity of virus-induced resistance to transplantation of polyoma and SV40 tumors in adult hamsters. Proc. Soc. exp. Biol. (N. Y.) 113, 4–12 (1963).
Koprowski, H., Jensen, F.C., Steplewski, Z.: Activation of production of infectious tumor virus SV40 in heterokaryon cultures. Proc. nat. Acad. Sci. (Wash.) 58, 127–133 (1967).
Kronman, B.S., Wepsic, H.T., Churchill, W.H., Jr., Zbar, B., Borsos, T., Rapp, H.J.: Tumor-specific antigens detected by inhibition of macrophage migration. Science, 165, 296–297 (1969).
Krupey, J., Gold, P., Freedman, S.O.: Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J. exp. Med. 128, 387–398 (1968).
Lamm, N., Boyse, E.A., Old, L.J., Lisowska-Bernstein, B., Stockert, E.: Modulation of TL (thymus-leukemia) antigen by Fab-fragments of TL antibody. J. Immunol. (in press).
Larson, V.M., Girardi, A.J., Hilleman, M.R., Zwickey, R.E.: Studies of oncogenicity of adenovirus type 7 viruses in hamsters. Proc. Soc. exp. Biol. (N. Y.) 118, 15–24 (1964).
Lavrin, D., Blair, P.B., Weiss, D.W.: Immunology of spontaneous mammary carcinomas in mice. III. Immunogenicity of C3H prenoplastic hyperplastic alveolar nodules in C3Hf hosts. Cancer Res. 26, 293–304 (1966).
Law, L.W.: Thymus: Role in resistance to polyoma virus oncogenesis. Science 147, 164–165 (1965).
Law, L.W.: Neoplasms in thymectomized mice following room infection with polyoma virus. Nature (Lond.) 205, 672–673 (1965).
Lawrence, H. S., Landy, M., eds.: Mediators of cellular immunity, p. 1–469. New York: Academic Press 1969.
Le François, D., Youn, J.K., Belahradek, J., Jr., Barski, G.: Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells. J. nat. Cancer Inst. 46, 981–988 (1971).
Lewis, M.G., Ikonopisov, R.L., Nairn, R.C., Phillips, T.M., Hamilton Fairley, G., Bodenham, D.C., Alexander, P.: Tumor-specific antibodies to human malignant melanoma and their relationship to the extent of the disease. Brit. med. J. 1969 III, 547–552.
Lezhneva, O.M.: A comparative study of the antigenic structure of the lactating mammary gland of high and low cancer strain mice. Probl. Oncol. 7, 62–66 (1961).
Lilien, J.E.: Toward a molecular explanation for specific cell adhesion. In: Moscona, A.A., Monroy, A., eds.: Durrent topics in developmental biology, vol. 4, p. 169–196. New York: Academic Press 1969.
Lilly, F.: In Dutcher, R.M., ed.: Comparative leukemia research 1969, p. 213–220 (Bibl. haemat. 36), Basel: Karger 1970.
Lilly, F.: Fv-2: Identification and Location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J. nat. Cancer Inst. 45, 163–169 (1970b).
Lilly, F., Boyse, E.A., Old, L.J.: Genetic basis of susceptibility to viral Leukaemogenesis. Lancet 1964 II, 1207–1208.
Lindner, O.E.A.: Survival of skin homografts in methylcholanthrene-treated mice and in mice with spontaneous mammary cancers. Cancer Res. 22, 380–383 (1962).
Lowy, D.R., Rowe, W.P., Teich, N., Hartley, J.W.: Murine leukemia virus: High-frequency activation in vitro by 5-Iododeoxyuridine and 5-bromodeoxy-uridine. Science 174, 155–156 (1971).
Maini, R.N., Bryceson, A.D.M., Wolstencroft, R.A., Dumonde, D.C.: Lymphocyte myogenic factor in vitro. Nature (Lond.) 224, 43–44 (1969).
Malmgren, R.A., Rabson, A.S., Carney, P.G.d: Immunity and viral carcinogenesis. Effect of thymectomy on polyoma virus carcinogenesis in mice. J. nat. Cancer Inst. 33, 101–104 (1964).
McDevitt, H.O., Benacerraf, B.: Genetic control of specific immune responses. Advanc. Immunol. 11, 31–74 (1969).
McKinnell, R.G., Deggins, B. A., Labat, D.D.: Transplantation of pluripotential nuclei from triploid frog tumors. Science 165, 394–395 (1969).
Mikulska, Z.B., Smith, C., Alexander, P.: Evidence for an immunological reaction of the host directed against its own actively growing primary tumor. J. nat. Cancer Inst. 36, 29–36 (1966).
Miller, J.F.A.P., Ting, R.C., Law, L.W.: Influence of thymectomy on tumor induction by polyoma virus in C57B1 mice. Proc. Soc. exp. Biol. (N. Y.) 116, 323–327 (1964).
Mizell, M. ed.: Recent results in cancer research. Biology of amphibian tumors, p. 1–484. Berlin-Heidelberg-New York: Springer 1969.
Möller, E.: Autoagonistic effects of humoral isoantibodies on the in vitro cytotoxicity of immune lymphoid cells. J. exp. Med. 122, 11–24 (1965).
Möller, G.: Demonstration of mouse isoantigens at the cellular level by the fluorescent antibody technique. J. exp. Med. 114, 415–440 (1961).
Möller, G.: Effect on tumour growth in syngeneic recipients of antibodies against tumour-specific antigens in methylcholanthrene-induced mouse sarcomas. Nature (Lond.) 204, 846–847 (1964).
Moloney, J.B.: The murine leukemias. Fed. Proc. 21, 19–31 (1962).
Morton, D.L.: Successful isoimmunization against a spontaneous mammary tumor in C3H HEN mice. Proc. Amer. Ass. Cancer Res. 3, 346 (1962).
Morton, D. L.: Acquired immunological tolerance to spontaneous mammary adenocarcinomas following neonatal infection with mammary tumor agent (MTA). Proc. Amer. Ass. Cancer Res. 5, 46 (1964).
Morton, D.L., Eilber, F.R., Malmgren, R.A., Wood, W.C.: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68, 158–164 (1970).
Morton, D.L., Goldman, L., Wood, D. A.: Immunological tolerance to spontaneous mammary adenocarcinomas (SMC). Proc. Amer. Ass. Cancer Res. 6, 47 (1965).
Morton, D.L., Malmgren, R.A.: Human osteosarcomas: Immunologic evidence suggesting an associated infectious agent. Science 162, 1279–1281 (1969).
Morton, D.L., Malmgren, R.A., Hall, W.T., Schidlovsky, G.: Immunologic and virus studies with human sarcomas. Surgery 66, 152–161 (1969).
Morton, D.L., Malmgren, R.A., Holmes, E.C., Ketcham, A.: Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64, 233–240 (1968).
Moscona, A.: The development in vitro of chimeric aggregates of dissociated embryonic chick and mouse cells. Proc. nat. Acad. Sci. (Wash.) 43, 184–194 (1957).
Muna, N., Marcus, S., Smart, C.: Detection of immunofluorescence of antibodies specific for human malignant melanoma cells. Cancer (Philad.) 23, 88–93 (1969).
Niederman, J.C., Evans, A.S., Subrahmanyan, L., McCollum, R.W.: Prevalence, incidence and persistence of EB virus antibody in young adults. New Engl. J. Med. 282, 361–365 (1970).
Nowinski, R.C., Old, L.J., Boyse, E.A., de Harven, E., Geering, G.: Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or gross leukemia virus. Virology 34, 617–629 (1968).
Nowinski, R.C., Old, L.J., Moore, D.H., Geering, G., Boyse, E.A.: A soluble antigen of the mammary tumor virus. Virology 31, 1–14 (1967).
Nowinski, R.C., Old, L.J., O’Donnell, P.V., Sanders, F.K.: Serological identification of hamster oncornaviruses. Nature (Lond.) New Biol. 230, 282–284 (1971).
Nowinski, R.C., Old, L.J., Sarkar, N.H., Moore, D.H.: Common properties of the oncogenic RNA viruses (oncornaviruses). Virology 42, 1152–1157 (1970).
Oettgen, H.F., Aoki, T., Geering, G., Boyse, E.A., Old, L.J.: Definition of an antigenic system associated with Burkitt’s lymphoma. Cancer Res. 27, 2532–2534 (1967).
Oettgen, H.F., Aoki, T., Old, L.J., Boyse, E.A., De Harven, E., Mills, G.: Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J. nat. Cancer Inst. 41, 827–844 (1968).
Oettgen, H.F., Hellström, K.E.: Tumor immunology. In: Holland, J.F., Frei, E. III, eds.: Cancer medicine, p. 951–990. Philadelphia: Lea and Febiger 1973.
Oettgen, H.F., Old, L.J., Boyse, E.A.: Human tumor immunology. Med. Clin. N. Amer. 55, 761–785 (1971).
Oettgen, H.F., Old, L.J., Farrow, J., Valentine, F., Lawrence, H.S., Thomas, L.: Effects of transfer factor in cancer patients. J. clin. Invest. 50, 71 a (1971).
Oettgen, H.F., Old, L.J., McLean, E.P., Carswell, E.A.: Delayed hypersensitivity and transplantation immunity by soluble antigens of chemically induced tumors in inbred guinea pigs. Nature (Lond.) 220, 295 (1968).
Ohno, S.: The role of geneduplication in vertebrate evolution. In: Bittar and Bittar, eds.: The biological basis of medicine, p. 109–130. London: Academic Press 1969.
Old, L.J., Benacerraf, B., Clarke, D.A., Carswell, E., Stockert, E.: The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res. 21, 1281–1300 (1961).
Old, L.J., Boyse, E.A.: Immunology of experimental tumors. Ann. Rev. Med. 15, 167–186 (1964).
Old, L.J., Boyse, E.A.: Antigens of tumors and leukemias induced by viruses. Fed. Proc. 24, 1009–1017 (1965).
Old, L.J., Boyse, E.A.: Specific antigens of tumors and leukemias of experimental animals. Med. Clin. N. Amer. 50, 901–912 (1966).
Old, L.J., Boyse, E.A.: Current enigmas in cancer research. The Harvey Lectures 67, 273–315 (1973).
Old, L.J., Boyse, E.A., Bennet, B., Lilly, F.: Peritoneal cells as an immune population in transplantation studies. In: Amos, B., Koprowski, H., eds.: Cell bound antibodies, p. 89–99. Philadelphia: Wistar Inst. Press 1963.
Old, L.J., Boyse, E.A., Clarke, D.A., Carswell, E.A.: Antigenic properties of chemically induced tumors. Ann. N. Y. Acad. Sci. 101, 80–106 (1962).
Old, L.J., Boyse, E.A., Geering, G., Oettgen, H.F.: Serologic approaches to the study of cancer in animals and in man. Cancer Res. 28, 1288–1299 (1968).
Old, L.J., Stockert, E., Boyse, E.A., Kim, J.H.: Antigenic modulation: Loss of TL antigen from cells exposed to TL antibody; study of the phenomenon in vitro. J. exp. Med. 127, 523–539 (1968).
Old, L.J., Boyse, E.A., Lilly, F.: Formation of cytotoxic antibody against leukemias induced by Friend virus. Cancer Res. 23, 1063–1068 (1963).
Old, L. J., Boyse, E. A., Stockert, E.: Antigenic properties of experimental leukemias. I. Serological studies in vitro with spontaneous and radiation-induced leukemias. J. nat. Cancer Inst. 31, 977–986 (1963).
Old, L.J., Boyse, E.A., Stockert, E.: Typing of mouse leukaemias by serological methods. Nature (Lond.) 201, 777–779 (1964).
Old, L. J., Boyse, E. A., Stockert, E.: The G (Gross) leukemia antigen. Cancer Res. 25, 813–819 (1965).
Oroszlan, S., Huebner, R.J., Gilden, R.V.: Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-Type. Virus. Proc. nat. Acad. Sci. (Wash.) 68, 901–904 (1971).
Pasternak, G.: Differentiation between viral and new cellular antigens in Graffi leukaemia of mice. Nature (Lond.) 214, 1364–1365 (1967).
Pasternak, G.: Serological studies on cells of Graffi virus-induced myeloid leukemia in mice. J. nat. Cancer Inst. 34, 71–83 (1965).
Pasternak, G., Graffi, A.: Induction of resistance against isotransplantation of virus-induced myeloid leukaemias. Brit. J. Cancer 17, 532–539 (1963).
Pereira, M.S., Pereira, H.G., Clark, S.K.R.: Human adenovirus type 31. A new serotype with oncogenic properties. Lancet 1965 I, 21–22.
Perlmann, P., Holm, G.: Cytotoxic effects of lymphoid cells in vitro. Advanc. Immunology 11, 117–193 (1969).
Pincus, T., Rowe, W.P., Lilly, F.: A major genetic locus affecting resistance to infection with Murine leukemia viruses. J. exp. Med. 133, 1234–1241 (1971).
Pope, J.H., Rowe, W.P.: Detection of specific antigen in SV40-transformed cells by immunofluorescence. J. exp. Med. 120, 121–128 (1964).
Pope, J.H., Rowe, W.P.: Immunofluorescent studies of adenovirus 12 tumors and of cells transformed or infected by adenovirus. J. exp. Med. 120, 577–588 (1964).
Prehn, R.T.: Specific isoantigenicities among chemically induced tumors. Ann. N.Y. Acad. Sci. 101, 107–113 (1962).
Prehn, R.T., Main, J. M.: Immunity to methylcholanthreneinduced sarcoma. J. nat. Cancer Inst. 18, 769–778 (1957).
Purves, L.R., Bersohn, I., Geddes, E.W.: Serum alphafetoprotein and primary cancer of the liver in man. Cancer (Philad.) 25, 1261–1270 (1970).
Prigogina, E. L., Stavrovskaja, A.A.: Identification and quantitative determination of myeloid chloroleukaemia virus with the aid of the resistance phenomenon. Nature (Lond.) 201, 934–936 (1964).
Rapp, F., Butel, J.S., Melnick, J.L.: Virusinduced intranuclear antigen in cells transformed by papovavirus SV40. Proc. Soc. exp. Biol. (N.Y.) 116, 1131–1135 (1964).
Rapp, F., Friend, C.: Early detection and localization of Swiss mouse leukemia virus. Acta Un. int. Cancr. 19, 348–350 (1963).
Rapp, F., Kitahara, T., Butel, J.S., Melnick, J.L.: Synthesis of SV40 tumor antigen during replication of simian papovavirus (SV40) Proc. nat. Acad. Sci. (Wash.) 52, 1138–1142 (1964).
Reif, A.E., Allen, J.M.V.: The AKR thymic antigen and its distribution in leukemias and nervous tissue. J. expt. Med. 120, 413–433 (1964).
Roizman, B.: Viruses affecting man and animals. Third International symposium Applied and Med. Virol. Fort Lauterdale, Florida, 1969. St. Louis: Wm.H. Green, 1970.
Rowe, W.P., Hartley, J.W.: Studies of genetic transmission of Murine leukemia virus by AKR mice. J. exp. Med. 136, 1286–1301 (1972).
Rubin, H.: The immunological basis for non-infective Rous sarcomas. Symp. quant. Biol. 27, 441–452 (1962).
Rubin, H.: Carcinogenic interactions between virus, cell and organism. J. Amer. med. Ass. 190, 727–731 (1964).
Rubin, H.: Virus defectiveness and cell transformation in the Rous sarcoma. J. cell. comp. Physiol. 64, 173–179 (1964).
Rubin, H., Fanshier, L., Cornelius, A., Hughes, W.F.: Tolerance and immunity in chickens after congenital and contact infection with an Avian leukosis virus. Virology 17, 143–156 (1962).
Sabin, A. B., Koch, M. A.: Source of genetic information for specific complement-fixing antigens in SV40 virusinduced tumors. Proc. nat. Acad. Sci. (Wash.) 52, 1131–1138 (1964).
Sabin, A.B., Shein, H.M., Koch, M.A., Enders, J.F.: Specific complement-fixing tumor antigens in human cells morphologically transformed by SV40 virus. Proc. nat. Acad. Sci. (Wash.) 52, 1316–1318 (1964).
Sabin, A.B., Koch, M.A.: Behavior of noninfectious SV40 viral genome in hamster tumor cells: Induction of synthesis of infectious virus. Proc. nat. Acad. Sci. (Wash.) 50, 407–417 (1963).
Sachs, L.: Tumor transplantation in mice inoculated with polyoma virus. Exp. Cell Res. 24, 185–196 (1961).
Sachs, L.: Transplantability of an X-ray-induced and a virus-induced leukemia in isologous mice inoculated with a leukemia virus. J. nat. Cancer Inst. 29, 759–764 (1962).
Sarma, P.S., Turner, H.C., Huebner, R.J.: An avian leucosis group-specific complement fixation reaction. Application for the detection and assay of noncytopathogenic leucosis viruses. Virology 23, 313–321 (1964).
Sarma, P.S., Baskar, J.F., Huebner, R.J., Old, L.J., Hardy, W.D., Jr.: In: Deutscher, R.M., ed.: Comparative leukemia research 1969, p. 368–378 (Bibl. Haematol. 36). Basel: Karger 1970.
Schäfer, W., Anderer, F.A., Bauer, H., Pister, L.: Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology 38, 387–394 (1969).
Schäfer, W., Lange, V., Pister, L., Seifert, E., de Noronha, F., Schmidt, F. W.: Eine Komplementbindungsreaktion zum Nachweis der bei Leukämieviren verschiedener Säuger vorkommenden gemeinsamen antigenen Komponente. Z. Naturforsch. B 25, 1029–1036 (1970).
Shigeno, Hämmerling, Arpels, Boyse, Old: Preparation of lymphocyte-specific antibody from anti-lymphocyte serum. Lancet 1968 II, 320–323.
Shope, R.E.: Immunization of rabbits to infectious papillomatosis. J. exp. Med. 65, 219–232 (1937).
Sjögren, H.O.: Some further studies on the induced resistance against isotransplantation of polyoma tumors. Virology 15, 214–219 (1961).
Sjögren, H.O.: Studies on specific transplantation resistance to polyoma-virus-induced tumors. I. Transplantation resistance induced by polyoma virus infection. J. nat. Cancer Inst. 32, 361–374 (1964).
Sjögren, H.O.: Studies on specific transplantation resistance to polyoma-virus-induced tumors. IV. Stability of the polyoma cell antigen. J. nat. Cancer Inst. 32, 661–666 (1964).
Sjögren, H. O.: Immunology in viral carcinogenesis. In: Immunity and tolerance in oncogenesis. Fourth Quadrennial, Perugia Cancer Conference. Edit. by L. Severi, p. 551–561. Perugia University Press 1970.
Sjögren, H.O., Borum, K.: Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats. Cancer Res. 31, 890–900 (1971).
Sjögren, H.O., Hellström, I., Klein, G.: Resistance of polyoma virus immunized mice to transplantation of established polyoma tumors. Exp. Cell Res. 23, 204–208 (1961).
Sjögren, H.O., Hellström, I., Klein, G.: Transplantation of polyoma virus-induced tumors in mice. Cancer Res. 21, 329 337 (1961).
Sjögren, H.O., Jonsson, N.: Resistance against isotransplantation of mouse tumors induced by Rous sarcoma virus. Exp. Cell Res. 32, 618–622 (1963).
Slettenmark, B., Klein, E.: Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against Gross lymphomas. Cancer Res. 22, 947–954 (1962).
Sonneborn, T. M.: The determination of hereditary antigenic differences in genically identical paramaecium cells. Proc. nat. Acad. Sci. (Wash.) 34, 413–513 (1948).
Southam, C.M.: Relationship of immunology to cancer—A review. Cancer Res. 20, 271–291 (1960).
Sperry, R.W.: Embryogenesis of behavioral nerve nets. In: De Haan and Ursprung, eds.: Organogenesis, p. 161. New York: Holt, Rinehart and Winston 1965.
Steeves, R.A.: Cellular antigen of Friend virus-induced leukemias. Cancer Res. 28, 338–342 (1968).
Stewart, T. H. M.: The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. Cancer (Philad.) 23, 1368–1379 (1969).
Stjernsward, J., Vanky, F.: Cellular immunity, its serum-mediated inhibition and tumor-destructive anergy to tumors in man. Third Internat. Conf. on Lymphatic Tissue and Germinal Centers in Immune Reactions, Uppsala 1970 (in press).
Stockert, E., Old, L.J., Boyse, E.A.: A cell surface allo-antigen associated with Murine leukemia virus; Implications regarding chromosomal integration of the viral genome. J. exp. Med. 133, 1334–1355 (1971).
Stück, B., Boyse, E.A., Old, L.J., Carswell, E.A.: ML: A new antigen found in leukaemias and mammary tumours of the mouse. Nature (Lond.) 203, 1033–1034 (1964).
Stück, B., Old, L.J., Boyse, E.A.: Antigenic conversion of established leukaemias by an unrelated leukaemogenic virus. Nature (Lond.) 202, 1016–1018 (1964).
Stück, B., Old, L.V., Boyse, E.A.: Occurrence of Soluble antigen in the plasma of mice with virus-induced leukemia. Proc. nat. Acad. Sci. (Wash.) 52, 950–958 (1964).
Svoboda, J., Chyle, P., Simkovic, D., Hilgert, I. S.: Demonstration of the absence of infectious Rous virus in rat tumor XC, whose structurally intact cells produce Rous sarcoma when transferred to chicks. Folia biol. (Praha) 9, 77 (1963).
Takahashi, Old: Surface alloantigens of plasma cells. J. exp. Med. 131, 1325–1341 (1970).
Thomas, L.: Discussion. In: Cellular and humoral aspects of hypersensitivity states, p. 529–534. New York: Hoeber Medical division, Harper & Row 1961.
Thomson, D. M. P., Krupey, J., Freedman, S. O., Gold, P.: The radioimmunoassay of circulating carcinoembryonic antigens of the human digestive system. Proc. nat. Acad. Sci. (Wash.) 64, 161–167 (1969).
Trentin, J. J., Bryan, E.: Immunization of hamsters and histoisogenic mice against transplantation of tumors induced by human adenovirus type 12. Proc. Amer. Ass. Cancer Res. 5, 64 (1964).
Viza, D.C., Bernard, Degani, O., Bernard, Cl., Harris, R.: Leukemia antigens. Lancet 1969 II, 493–494.
Vogt, P.K., Sarma, P.S., Huebner, R.J.: Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken. Virology 27, 233–236 (1965).
Wahren, B.: Cytotoxic assays and other immunologic studies of leukemias induced by Friend virus. J. nat. Cancer Inst. 31, 411–423 (1963).
Wahren, B.: Further studies of the immunological properties of Gross virus induced lymphomas. Cancer Res. 24, 906–914 (1964).
Wahren, B.: Comparison of tumour antigens in AKR and Gross virus (passage A)-induced leukaemias. Nature (Lond.) 205, 409–410 (1965).
Watkins, J.F., Dulbecco, R.: Production of SV40 virus in heterokaryons of transformed and susceptible cells. Proc. nat. Acad. Sci. (Wash.) 58, 1396–1409 (1967).
Weiss, P., Quart: Perspectives in the field of morphogenesis. Rev. Biol. 25, 177–198 (1950).
Weiss, D.W., Faulkin, L.J., DeOme, K.B.: Acquired resistance to spontaneous mammary carcinomas in autochthonous and isologous mice. Proc. Amer. Ass. Cancer Res. 4, 280 (1963).
Weiss, D.W., Faulkin, L. J., DeOme, K.B.: Acquisition of heightened resistance and susceptibility to spontaneous mouse mammary carcinomas in the original host. Cancer Res. 24, 732–741 (1964).
Winn, H.J.: The immune response and the homograft reaction. J. nat. Cancer Inst. Monogr. 2, 113–138 (1960).
Wood, W.C., Morton, D.L.: Microcytotoxicity test: Detection in sarcoma patients of antibody cytotoxic to human sarcoma cells. Science 170, 1318–1320 (1970).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Oettgen, H.F. (1974). Immunologische Aspekte des Krebses. In: Grundmann, E. (eds) Geschwülste · Tumors I. Handbuch der allgemeinen Pathologie, vol 6 / 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65895-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-65895-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65897-6
Online ISBN: 978-3-642-65895-2
eBook Packages: Springer Book Archive